PERCEPTIVE ADVISORS LLC Q3 2021 Filing
Filed November 15, 2021
Portfolio Value
$6.9B
Holdings
139
Report Date
Q3 2021
Filing Type
13F-HR
All Holdings (139 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MRTXEURMIRATI THERAPEUTICS INC | 3,387,745 | $599.3B | 8702.19% | |
| 2 | TVTX 2.5 09/15/25TRAVERE THERAPEUTICS INC | 45,000,000 | $454.8B | 6604.03% | |
| 3 | BBIOBRIDGEBIO PHARMA INC | 7,756,928 | $363.6B | 5278.98% | |
| 4 | SWTXSPRINGWORKS THERAPEUTICS INC | 4,849,912 | $307.7B | 4467.47% | |
| 5 | IOVAIOVANCE BIOTHERAPEUTICS INC | 11,489,772 | $283.3B | 4114.04% | |
| 6 | AM6AMICUS THERAPEUTICS INC | 26,559,443 | $253.6B | 3682.89% | |
| 7 | —LANDOS BIOPHARMA INC | 14,869,915 | $217.1B | 3152.30% | |
| 8 | HZNPHORIZON THERAPEUTICS PUB L | 1,956,940 | $214.4B | 3112.54% | |
| 9 | —COLLEGIUM PHARMACEUTICAL INC | 17,500,000 | $180.3B | 2617.22% | |
| 10 | VAC2USDVBI VACCINES INC CDA | 55,042,465 | $171.2B | 2485.56% | |
| 11 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 5,175,867 | $152.7B | 2217.02% | |
| 12 | NVRO 2.75 04/01/25NEVRO CORP | 9,000,000 | $126.2B | 1832.91% | |
| 13 | OPHTEURIVERIC BIO INC | 7,471,798 | $121.3B | 1761.88% | |
| 14 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 4,407,399 | $112.3B | 1630.59% | |
| 15 | NVTA1EURINVITAE CORP | 3,923,741 | $111.6B | 1619.72% | |
| 16 | —ZYMEWORKS INC | 3,679,845 | $106.9B | 1551.65% | |
| 17 | CCCCC4 THERAPEUTICS INC | 2,258,566 | $100.9B | 1465.25% | |
| 18 | OMGBPOUTSET MED INC | 1,990,633 | $98.4B | 1429.01% | |
| 19 | MGTXMEIRAGTX HLDGS PLC | 6,948,277 | $91.6B | 1329.71% | |
| 20 | RAPTEURRAPT THERAPEUTICS INC | 2,907,565 | $90.3B | 1310.86% | |
| 21 | ALDXALDEYRA THERAPEUTICS INC | 9,903,879 | $87.0B | 1262.60% | |
| 22 | CRNXCRINETICS PHARMACEUTICALS IN | 3,963,517 | $83.4B | 1211.43% | |
| 23 | AVIRATEA PHARMACEUTICALS INC | 2,259,224 | $79.2B | 1150.10% | |
| 24 | —PROMETHEUS BIOSCIENCES INC | 3,314,032 | $78.6B | 1140.92% | |
| 25 | CHRSCOHERUS BIOSCIENCES INC | 4,779,387 | $76.8B | 1115.21% | |
| 26 | BDQMALBIREO PHARMA INC | 2,360,139 | $73.6B | 1069.19% | |
| 27 | RCKTROCKET PHARMACEUTICALS INC | 2,310,261 | $69.1B | 1002.66% | |
| 28 | PRCTPROCEPT BIOROBOTICS CORP | 1,656,990 | $63.2B | 917.87% | |
| 29 | RLAYRELAY THERAPEUTICS INC | 1,943,097 | $61.3B | 889.58% | |
| 30 | —ICOSAVAX INC | 1,922,549 | $56.9B | 826.01% | |
| 31 | NAUTNAUTILUS BIOTECHNOLOGY INC | 8,911,151 | $54.7B | 794.45% | |
| 32 | KRON1USDKRONOS BIO INC | 2,421,142 | $50.7B | 736.84% | |
| 33 | MORFMORPHIC HLDG INC | 887,340 | $50.3B | 729.76% | |
| 34 | —COHERUS BIOSCIENCES INC | 4,500,000 | $49.4B | 716.78% | |
| 35 | TVTXTRAVERE THERAPEUTICS INC | 1,965,555 | $47.7B | 692.09% | |
| 36 | BEAMBEAM THERAPEUTICS INC | 537,635 | $46.8B | 679.24% | |
| 37 | NBIXNEUROCRINE BIOSCIENCES INC | 483,007 | $46.3B | 672.64% | |
| 38 | VRCAVERRICA PHARMACEUTICALS INC | 3,610,412 | $45.1B | 655.29% | |
| 39 | MGNXMACROGENICS INC | 2,148,060 | $45.0B | 653.11% | |
| 40 | KODKODIAK SCIENCES INC | 461,248 | $44.3B | 642.81% | |
| 41 | ATNXEURATHENEX INC | 13,532,467 | $40.7B | 591.44% | |
| 42 | VERUEURVERU INC | 4,451,342 | $38.0B | 551.32% | |
| 43 | —RAIN THERAPEUTICS INC | 2,537,019 | $38.0B | 551.09% | |
| 44 | —QUOTIENT LTD | 16,200,818 | $37.9B | 550.45% | |
| 45 | —DBV TECHNOLOGIES S A | 7,695,505 | $37.7B | 547.52% | |
| 46 | INBXUSDINHIBRX INC | 1,121,490 | $37.4B | 542.42% | |
| 47 | ESTAESTABLISHMENT LABS HLDGS INC | 505,541 | $36.2B | 525.42% | |
| 48 | —SINGULAR GENOMICS SYSTEMS IN | 3,073,824 | $34.4B | 499.43% | |
| 49 | LPTXEURLEAP THERAPEUTICS INC | 8,476,496 | $34.0B | 493.53% | |
| 50 | TMCITREACE MED CONCEPTS INC | 1,235,886 | $33.2B | 482.72% | |
| 51 | —CAREMAX INC | 3,385,000 | $32.7B | 474.79% | |
| 52 | IMTXIMMATICS N.V | 2,500,000 | $32.5B | 471.90% | |
| 53 | —ATHIRA PHARMA INC | 3,425,916 | $32.1B | 466.60% | |
| 54 | SLDBSOLID BIOSCIENCES INC | 13,412,552 | $32.1B | 465.45% | |
| 55 | XENEXENON PHARMACEUTICALS INC | 2,022,051 | $30.9B | 448.62% | |
| 56 | NVROEURNEVRO CORP | 259,972 | $30.3B | 439.32% | |
| 57 | NUVBNUVATION BIO INC | 3,041,004 | $30.2B | 438.91% | |
| 58 | HCATHEALTH CATALYST INC | 589,004 | $29.5B | 427.70% | |
| 59 | LYRALYRA THERAPEUTICS INC | 3,222,560 | $29.4B | 426.93% | |
| 60 | TARSTARSUS PHARMACEUTICALS INC | 1,296,416 | $27.9B | 405.64% | |
| 61 | COGTCOGENT BIOSCIENCES INC | 3,188,750 | $26.8B | 389.38% | |
| 62 | UTHUNITED THERAPEUTICS CORP DEL | 141,700 | $26.2B | 379.77% | |
| 63 | SLGCUSDSOMALOGIC INC | 2,050,000 | $25.4B | 368.81% | |
| 64 | CCXIEURCHEMOCENTRYX INC | 1,473,200 | $25.2B | 365.77% | Call |
| 65 | BCABBIOATLA INC | 850,026 | $25.0B | 363.36% | |
| 66 | VRDNVIRIDIAN THERAPEUTICS INC | 1,423,000 | $23.4B | 339.88% | |
| 67 | RNAAVIDITY BIOSCIENCES INC | 885,818 | $21.8B | 316.80% | |
| 68 | TCE2CELLDEX THERAPEUTICS INC NEW | 393,613 | $21.3B | 308.56% | |
| 69 | APLSAPELLIS PHARMACEUTICALS INC | 615,000 | $20.3B | 294.32% | |
| 70 | SMFRUSDSEMA4 HOLDINGS CORP | 2,500,000 | $19.0B | 275.52% | |
| 71 | HRMYHARMONY BIOSCIENCES HLDGS IN | 491,332 | $18.8B | 273.45% | |
| 72 | HLTHQCUE HEALTH INC | 1,580,607 | $18.7B | 271.04% | |
| 73 | IMRXIMMUNEERING CORP | 681,051 | $18.1B | 262.55% | |
| 74 | NTRANATERA INC | 160,000 | $17.8B | 258.89% | |
| 75 | TYRATYRA BIOSCIENCES INC | 987,500 | $17.4B | 252.21% | |
| 76 | CATBUSDASTRIA THERAPEUTICS INC | 1,959,652 | $17.3B | 251.53% | |
| 77 | ABSIABSCI CORPORATION | 1,476,776 | $17.2B | 249.38% | |
| 78 | NUVLNUVALENT INC | 750,000 | $16.9B | 245.58% | |
| 79 | VRNAVERONA PHARMA PLC | 2,888,889 | $15.8B | 229.87% | |
| 80 | —AGILE THERAPEUTICS INC | 15,919,925 | $15.3B | 222.17% | |
| 81 | ADMAADMA BIOLOGICS INC | 13,262,375 | $15.0B | 217.60% | |
| 82 | —HEALTHCOR CATALIO ACQU CORP | 1,500,000 | $14.8B | 215.62% | |
| 83 | IMCRIMMUNOCORE HLDGS PLC | 400,000 | $14.8B | 215.30% | |
| 84 | GRPHGRAPHITE BIO INC | 875,093 | $14.3B | 208.26% | |
| 85 | ACRSACLARIS THERAPEUTICS INC | 781,236 | $14.1B | 204.18% | |
| 86 | BIIBBIOGEN INC | 48,600 | $13.8B | 199.69% | |
| 87 | VTRSVIATRIS INC | 1,004,419 | $13.6B | 197.62% | |
| 88 | DAWNDAY ONE BIOPHARMACEUTICALS I | 556,047 | $13.2B | 191.59% | |
| 89 | —CM LIFE SCIENCES III INC | 1,250,000 | $12.8B | 186.04% | |
| 90 | NSTG 2.625 03/01/25NANOSTRING TECHNOLOGIES INC | 1,000,000 | $12.8B | 185.84% | |
| 91 | PODDINSULET CORP | 44,522 | $12.7B | 183.74% | |
| 92 | NBTXNANOBIOTIX SA | 1,059,800 | $12.0B | 174.81% | |
| 93 | ADPTADAPTIVE BIOTECHNOLOGIES COR | 352,804 | $12.0B | 174.12% | |
| 94 | ACCDEURACCOLADE INC | 279,774 | $11.8B | 171.31% | |
| 95 | —ZYMERGEN INC | 883,332 | $11.6B | 168.91% | |
| 96 | CLOVCLOVER HEALTH INVESTMENTS CO | 1,500,000 | $11.1B | 160.95% | |
| 97 | —1LIFE HEALTHCARE INC | 532,350 | $10.8B | 156.53% | |
| 98 | KYMRKYMERA THERAPEUTICS INC | 180,000 | $10.6B | 153.52% | |
| 99 | —ONCORUS INC | 1,099,810 | $10.3B | 149.15% | |
| 100 | FDMT4D MOLECULAR THERAPEUTICS IN | 375,256 | $10.1B | 146.96% |
Page 1 of 2Next